Alzheimer’s disease — New Breathe

Status	Study	Conditions	Interventions	Locations
Recruiting	Digital Cognitive Remote Training in Alzheimer’s Disease (MA-EIAD)	Alzheimer’s Disease	Behavioral: Control – Cognitive training in a practitioner’s office one time per week Behavioral: Experimental group 1 – Cognitive training in a practitioner’s office one time per week and cognitive distance training one time per week Behavioral: Experimental group 2 – Cognitive training in a practitioner’s office one time per week and cognitive distance training four times per week	Service de Neuropsychologie – Hôpital Neurologique, Hospices Civils de Lyon Bron, France
Recruiting	A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer’s Disease (AD)	Alzheimer’s Disease	Other: Placebo Biological: Bepranemab	Ah0003 50428 Fresno, California, United States Ah0003 50431 Fullerton, California, United States Ah0003 50447 San Diego, California, United States (and 57 more…)
Recruiting	Early Onset Alzheimer’s Disease Genomic Study	Alzheimer’s Disease	Genetic: Genetic Testing	Baylor Scott & White AT&T Memory Center Dallas, Texas, United States
Unknown	Memantine Treatment in Alzheimer’s Disease Patients	Alzheimer’s Disease	Drug: Memantine Hydrochloride
Recruiting	Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer’s Disease	Alzheimer’s Disease	Drug: CT1812; Drug: Placebo	Clinilabs Drug Development Corporation New York, New York, United States University of Pennsylvania Philadelphia, Pennsylvania, United States
Unknown	Alzheimer’s Disease, Art and Garden	Alzheimer’s Disease	Behavioral: Cognitive and psycho-behavioral effects of an artistic dimension	CHU Nancy Nancy, France
Recruiting	Alzheimer’s Disease Stem Cells Multiple Infusions	Alzheimer’s Disease	Biological: Approximately 100 million cells allogeneic hMSC	University of Miami Miami, Florida, United States
Recruiting	MK-1942/Donepezil Interactions in Participants With Alzheimer’s Disease (MK-1942-005)	Alzheimer’s Disease	Drug: MK-1942; Drug: Donepezil; Drug: Placebo	Woodland Research Northwest, LLC ( Site 0004) Rogers, Arkansas, United States
Recruiting	ADvance II Study: DBS-f in Patients With Mild Alzheimer’s Disease	Alzheimer’s Disease	Device: DBS-f On; Device: DBS Off	Barrow Neurological Institute Phoenix, Arizona, United States; University of Southern California Los Angeles, California, United States; (and 19 more…)

BACK TO STUDIES

<img src="https://newbreathe.org/wp-content/uploads/2021/04/NewBreathe_logo.png" alt="New Breathe" title="New Breathe" >

<img src="https://newbreathe.org/wp-content/uploads/2021/04/NewBreathe_logo.png" alt="New Breathe" title="New Breathe" >

0-800-777-2331

Call us now if you are in a medical emergency need, we will reply swiftly and provide you with a medical aid.

2021 © New Breathe. Powered with ❤ by Goweb Agency.

2021 © New Breath. Powered with ❤ by Goweb Agency.